Advertisement
Original Communications| Volume 125, ISSUE 1, P53-59, January 1999

Fibrin sealant inhibits connective tissue deposition in a murine model of peritoneal adhesion formation

      Abstract

      Background: Postoperative peritoneal adhesion formation causes a multitude of disorders, including bowel obstruction and infertility. Methods: To test whether fibrin sealant inhibits adhesion formation, mice were given an intraperitoneal injection of talc (to induce adhesions) after which sealant was administered. Seven and 14 days later, the thickness of connective tissue between the fragmented mesothelium and the abdominal muscle was measured. Results: At both 7 and 14 days after talc administration, talc-treated mice had a 6-fold increase in connective tissue thickness over vehicle alone (P < .05). Although fibrin sealant alone failed to trigger peritoneal pathologic conditions, administration of sealant to talc-treated mice inhibited connective tissue deposition by 80% at 7 and 14 days (P < .05). Additionally, delaying fibrin sealant administration up to and including 72 hours after talc treatment results in comparable inhibition of connective tissue deposition, as does treatment immediately after talc exposure. Conclusions: This study demonstrates that fibrin sealant inhibits peritoneal inflammation and peritoneal adhesion formation with use of a quantitative assay of connective tissue deposition. In addition, this is the first report to document the administration of fibrin sealant into the closed abdomen. The success of these studies suggests that fibrin sealant will block peritoneal adhesions when administered laparoscopically. Finally, because fibrin sealant is therapeutic even when administered after the initiation of peritoneal inflammation, it suggests that it may be efficacious in patients who present with adhesions or those undergoing multiple operations. (Surgery 1999;125:53-9.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ellis H
        The causes and prevention of intestinal adhesions.
        Br J Surg. 1982; 69: 241-243
        • Gauwerky J
        • Mann J
        • Bastert G
        The effect of fibrin glue and peritoneal grafts in the prevention of intraperitoneal adhesions.
        Arch Gynecol Obstet. 1990; 247: 161
        • Sheppard B
        • De Virgilio C
        • Bleiweis M
        • Milliken J
        • Robertson J
        Inhibition of intra-abdominal adhesions: fibrin glue in a long term model.
        Am Surg. 1993; 59: 786-790
        • de Virgilio C
        • Dubrow T
        • Sheppard B
        • MacDonald W
        • Nelson R
        • Lesavoy M
        • et al.
        Fibrin glue inhibits intra-abdominal adhesion formation.
        Arch Surg. 1990; 125: 1378
        • Lindenberg S
        • Steentoft P
        • Sorensen S
        • Oleson H
        Studies on prevention of intra-abdominal adhesion formation by fibrin sealant.
        Acta Chir Scand. 1985; 151: 525-527
        • Chmielewski G
        • Saxe J
        • Dulchavsky S
        • Diebel L
        • Bailey J
        Fibrin gel limits intra-abdominal adhesion formation.
        Am Surg. 1992; 58: 590-593
        • Evrard VA
        • De Belles S
        • Boeckx W
        • Brosens LA
        Peritoneal healing after fibrin glue application: a comparative study in a rat model.
        Hum Reprod. 1996; 11: 1877-1880
        • De Iaco PA
        • Costa A
        • Mazzoleni G
        • Pasquinelli G
        • Bassein L
        • Marabini A
        Fibrin sealant in laparoscopic adhesion prevention in the rabbit uterine horn model.
        Fertil Steril. 1994; 62: 400-404
        • Harris ES
        • Morgan RF
        • Rodenheaver GT
        Kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents.
        Surgery. 1995; 117: 663-669
        • Takuchi H
        • Awaji M
        • Hashimoto M
        • Nakano Y
        • Mitsuhashi N
        • Kuwabara Y
        Reduction in adhesions with fibrin glue after laparoscopic excision of large ovarian endometriomas.
        J Am Assoc Gynecol Laparosc. 1996; 3: 575-579
        • Gibble J
        • Ness P
        Fibrin glue: the perfect operative sealant?.
        Transfusion. 1990; 30: 741-747
        • Spotnitz W
        Fibrin sealant in the United States: clinical use at the University of Virginia.
        Thromb Haemost. 1995; 74: 482-485
        • Byrne D
        • Hardy R
        • Wood R
        • Mclntosh R
        • Hopwood D
        • Cuschier A
        Adverse influence of fibrin sealant on the healing of high-risk sutured colonic anastomoses.
        J R Coll Surg Edinb. 1992; 37: 394-398
        • van der Ham A
        • Kort W
        • Weijma I
        • Jeekel H
        Transient protection of incomplete colonic anastomoses with fibrin sealant: an experimental study in the rat.
        J Surg Res. 1993; 55: 256-260
        • Marana R
        • Muzii L
        • Catalano G
        • Caruana P
        • Mancuso S
        Use of fibrin sealant for reproductive surgery: a randomized study in the rabbit model.
        Gynecol Obstet Invest. 1996; 41: 199-202
        • van der Ham A
        • Kort W
        • Weijma I
        • van den Ingh H
        • Jeekel H
        Healing of ischemic colonic anastomosis: fibrin sealant does not improve wound healing.
        Dis Colon Rectum. 1992; 35: 884-891
        • Myllarniemi H
        • Frilander M
        • Turunen M
        • Saxen L
        The effect of glove powders and their constituents on adhesion and granuloma formation in the abdominal cavity.
        Acta Chir Scand. 1966; 131: 312-318
        • Frazier-Jessen MR
        • Kovacs EJ
        Abdominal wall thickness as a means of assessing peritoneal fibrosis in mice.
        J Immunol Methods. 1993; 162: 115-121
        • Frazier-Jessen MR
        • Mort FJ
        • Witte PL
        • Kovacs EJ
        Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesions formation.
        J Immunol. 1996; 156: 3036-3042
        • Buckman R
        • Woods M
        • Sargent L
        • Gervin A
        A unifying pathogenic mechanism in the etiology of intraperitoneal adhesions.
        J Surg Res. 1976; 20: 1-5
        • Vipond M
        • Whawell S
        • Thompson J
        • Dudley H
        Peritoneal fibrinolytic activity and intra-abdominal adhesions.
        Lancet. 1990; 335: 1120-1122
        • Liebovich S
        • Ross R
        The role of the macrophage in wound repair.
        Am J Pathol. 1975; 78: 71-100
        • Weil SJ
        • Wang S
        • Perez MC
        • Lyttle LR
        Chemotaxis of macrophages by a peritoneal fluid protein in women with endometriosis.
        Fertil Steril. 1997; 67: 865-869
        • Bos HJ
        • Boorsman DM
        • Tuk CW
        • De Veld JC
        • Van Der Muysenberg AJC
        • Helmerhorst TJM
        • et al.
        Chemotaxis of peritoneal cells and the detection of a chemoattractant in the effluent from peritoneal dialysis patients.
        Eur J Clin Invest. 1990; 20: 555-562
        • Shimakado K
        • Raines EW
        • Madtes DK
        • Barrett TB
        • Bendett EP
        • Ross R
        A significant part of macrophage-derived growth factor consists of at least two forms of PDGF.
        Cell. 1985; 43: 227-286
        • Halme J
        • White C
        • Kauma S
        • Estes J
        • Haskill S
        Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro.
        J Clin Endocrinol Metab. 1988; 66: 1044-1049
        • Frazier-Jessen MR
        • Kovacs EJ
        Estrogen regulation of JE/MCP-1 mRNA expression in macrophages.
        J Immunol. 1995; 154: 1838-1845
        • Kovacs EJ
        Fibrogenic cytokines: the role of immune mediators in the development of scar tissue.
        Immunol Today. 1991; 12: 17-23
        • Chegini N
        The role of growth factors in peritoneal healing: transforming growth factor-β (TGFβ).
        Eur J Surg. 1997; 577: 17-23
        • Kovacs EJ
        • Brock B
        • Silber I
        • Neuman JE
        Production of fibrogenic cytokines by interleukin-2-treated peripheral blood leukocytes: expression of transforming growth factor β and platelet-derived growth factor β chain genes.
        Obstet Gynecol. 1993; 83: 29-36
        • Kovacs EJ
        • DiPietro LA
        Fibrogenic cytokines and connective tissue production.
        FASEB J. 1994; 8: 854-861
        • Fukasawa M
        • Campeau J
        • Girgis W
        • Bryant S
        • Rodgers K
        • diZerega G
        Production of protease inhibitors by postsurgical macrophages.
        J Surg Res. 1989; 46: 256-261
        • Colotta F
        • Sciacca FL
        • Sironi M
        • Luini W
        • Rabiet RJ
        • Montovani A
        Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin.
        Am J Pathol. 1994; 144: 975-985
        • Dvorak H
        • Harvey V
        • Estrella P
        • Brown L
        • McDonagh J
        • Dvorak A
        Fibrin containing gels induce angiogenesis.
        Lab Invest. 1987; 57: 673-686
        • Tsopanoglou N
        • Pipili-Synetos E
        • Maragoudakis M
        Thrombin promotes angiogenesis by a mechanism independent of fibrin formation.
        Am J Physiol. 1993; 264: C1302-C1307
        • diZerega GS
        Biochemical events in peritoneal tissue repair.
        Eur J Surg. 1997; : 10-16